Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway
Frontiers in Pharmacology · 21.08.2026 · 17
DOI: 10.3389/fphar.2026.1786264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 21.08.2026. Verfasst von Xueyu Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Medical University Clinical Medical College, Guiyang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders affecting women of reproductive age. Dendrobium officinale polysaccharides (DOP) have shown multiple pharmacological activities, but their therapeutic effects and underlying mechanisms in PCOS remain incompletely understood.
Methods
A dehydroepiandrosterone (DHEA)-induced mouse model of PCOS was established to evaluate the effects of DOP. Estrous cyclicity, ovarian histopathology, serum hormone levels, RT-qPCR, and Western blot analyses were performed to assess reproductive function, endocrine changes, and MAPK/ERK-related signaling.
Results
DOP treatment restored estrous cyclicity, improved ovarian morphology, and partially normalized serum luteinizing hormone, follicle-stimulating hormone, and testosterone levels. In addition, DOP reduced ERK1/2 phosphorylation and downregulated the expression of CYP17A1 and CYP19A1.
Conclusion
DOP ameliorated reproductive and endocrine abnormalities in a DHEA-induced mouse model of PCOS. The findings suggest that modulation of MAPK/ERK signaling may contribute to the biological effects of DOP, although further mechanistic studies are required to establish causal relationships.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guizhou Medical University Clinical Medical College, Guiyang, China.
- Gynecology Department, Anshun People's Hospital, Anshun, China.
- Guizhou Natural Products Research Center, Guiyang, China.
Zitieren
APA
Qin, X., Lu, Y., Zeng, P., Huang, G., Luo, H., & Zhao, S. (2026). Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1786264
Vancouver
Qin X, Lu Y, Zeng P, Huang G, Luo H, Zhao S. Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1786264
BibTeX
@article{Qin2026,
author = {Qin, Xueyu and Lu, Yongyan and Zeng, Peng and Huang, Guanyou and Luo, Heng and Zhao, Shuyun},
title = {Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1786264}
}
EUVIMED